Trial results

$FTH — PIKTOR

Faeth Therapeutics, Inc. (FTH) PIKTOR: trial results in Endometrial cancer, 2026.

Research by Catalyst Intel

The catalyst

"PIKTOR is being evaluated in a Phase 2 trial in second-line advanced endometrial cancer (Study FTH-PIK-201), with topline data anticipated by year-end 2026."

— Faeth Therapeutics, 8-K filed 2026-11-03 · the filing. Checked word for word against the stored document when this page was built; a sentence that did not check out would not be here.

Event id

FTH-PIKTOR-2026

Company

Faeth Therapeutics, Inc.

Kind

Trial results

Indication

Endometrial cancer

Window

2026-01-01 – 2026-12-31

Status

dropped

The bar

No bar has been published for this event yet.

Verdicts

No verdict has been published for this event yet.